Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003135656 | SCV003809253 | uncertain significance | not provided | 2019-10-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004985293 | SCV005603588 | uncertain significance | Inborn genetic diseases | 2024-11-14 | criteria provided, single submitter | clinical testing | The c.2599G>A (p.G867R) alteration is located in exon 19 (coding exon 19) of the HSPG2 gene. This alteration results from a G to A substitution at nucleotide position 2599, causing the glycine (G) at amino acid position 867 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |